ChemicalBook--->CAS DataBase List--->184475-56-7

184475-56-7

184475-56-7 Structure

184475-56-7 Structure
IdentificationBack Directory
[Name]

4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline dihydrochloride
[CAS]

184475-56-7
[Synonyms]

Gefitinib dihydrochloride
4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline dihydrochloride
[Molecular Formula]

C22H25Cl2FN4O3
[MDL Number]

MFCD12913912
[MOL File]

184475-56-7.mol
[Molecular Weight]

483.37
Safety DataBack Directory
[HS Code ]

2934999090
Hazard InformationBack Directory
[Uses]

Gefitinib (ZD 1839) dihydrochloride is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib dihydrochloride selectively inhibits EGF-stimulated tumor cell growth (IC50 of 54 nM) and blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib dihydrochloride also induces autophagy and cell apoptosis, which can be used for cancer related research, such as Lung cancer and breast cancer [1][2][5].
[in vivo]

Gefitinib dihydrochloride (Oral administration, 75 mg/kg/d, 21 days) inhibits the M2-like polarization of macrophages in LLC mice metastasis model[3].
Gefitinib dihydrochloride (Oral administration, 75 mg/kg for the initial week, daily for 5 consecutive days per week) eliminates phosphorylation of HER2 and HER3 and signaling through MAPK and Akt in lobular hyperplasias and carcinomas, increases MAPK activity and cytokine production in splenocytes and lymph nodes[5].
Gefitinib dihydrochloride (Oral gavage, 150 mg/kg, daily) enhances the anti-tumor effect of Cisplatin in H358R xenograft[7].

Animal Model:LLC mice metastasis model[3]
Dosage:75 mg/kg/d, for 21 days.
Administration:Oral administration
Result:Reduced the number of lung metastasis nodules, down-regulated the expression of M2 marker genes and the percentages CD206+ and CD68+ macrophages in tumor tissues.
Animal Model:BALB-NeuT transgenic mouse model[5]
Dosage:75 mg/kg for the initial week, and increased by 15 mg/kg every other week, daily for 5 consecutive days per week, followed by 2 days without treatment and repeated for 8–9 weeks.
Administration:Oral administration
Result:Reduced tumor multiplicity from 9.6 to 0.58 (83%), and reduced the number and size of lobules and lobular nodules in treated mice.
[References]

[1] Wakeling AE, et al. ZD1839: an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Res. 2002 Oct 15;62(20):5749-54. PMID:12384534
[2] Pedersen MW, et al. Differential response to gefitinib of cells expressing normal EGFR and the mutant EGFRvIII. Br J Cancer. 2005 Oct 17;93(8):915-23. DOI:10.1038/sj.bjc.6602793
[3] Muhammad Tariq, et al. Gefitinib inhibits M2-like polarization of tumor-associated macrophages in Lewis lung cancer by targeting the STAT6 signaling pathway. Acta Pharmacol Sin. 2017 Nov;38(11):1501-1511. DOI:10.1038/aps.2017.124
[4] Mark S Cragg, et al. Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics. PLoS Med. 2007 Oct;4(10):1681-89; discussion 1690. DOI:10.1371/journal.pmed.0040316
[5] Marie P Piechocki, et al. Gefitinib prevents cancer progression in mice expressing the activated rat HER2/neu. Int J Cancer. 2008 Apr 15;122(8):1722-9. DOI:10.1002/ijc.23231
[6] Tomoya Takenaka, et al. Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells. Int J Pharm. 2019 Dec 15;572:118762. DOI:10.1016/j.ijpharm.2019.118762
[7] Amin Li, et al. Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells. J Cancer Res Clin Oncol. 2020 Jul;146(7):1737-1749. DOI:10.1007/s00432-020-03228-4
184475-56-7 suppliers list
Company Name: Dalian Meilun Biotech Co., Ltd.  
Telephone: 0411-62910999 13889544652
Website: http://www.meilunbio.com/
Company Name: Shanghai T&W Pharmaceutical Co., Ltd.  
Telephone: +86 21 61551611
Website: www.trustwe.com
Company Name: The future of Shanghai Industrial Co., Ltd.  
Telephone: 021-61552785
Website: www.jonln.com
Company Name: Shanghai JONLN Reagent Co., Ltd.  
Telephone: 400-0066400 13621662912
Website: http://www.jonln.com
Company Name: Shanghai YuLue Chemical Co., Ltd.  
Telephone: 021-60345187 13671753212
Website: https://www.chemicalbook.com/ShowSupplierProductsList16365/0_EN.htm
Company Name: Credit Asia Chemical Co., Ltd.  
Telephone: +86 (21) 61124340
Website: www.chemicalbook.com/ShowSupplierProductsList16523/0_EN.htm
Company Name: Guangzhou Ciming Biological Technology Co., Ltd.  
Telephone: 020-38082199,29065168,38082986,29878298,29866629,4000192398
Website: www.chemicalbook.com/ShowSupplierProductsList16517/0_EN.htm
Company Name: Amadis Chemical Company Limited  
Telephone: 571-89925085
Website: http://www.amadischem.com
Company Name: Nanjing crow LuNing pharmaceutical technology co., LTD  
Telephone: 13382066392
Website: www.chemicalbook.com/ShowSupplierProductsList30681/0_EN.htm
Company Name: Hefei TNJ Chemical Industry Co.,Ltd.  
Telephone: +86-0551-65418684 +86-18949823763
Website: www.tnjchem.com
Company Name: Dayang Chem (Hangzhou) Co.,Ltd.  
Telephone: +86-0571-88938639 17705817739
Website: www.dycnchem.com/
Company Name: SIMAGCHEM CORP  
Telephone: +86-5922680277 +86-13806087780
Website: http://www.simagchem.com/
Company Name: CONIER CHEM AND PHARMA LIMITED  
Telephone:
Website: http://www.conier.com/
Company Name: Zhejiang Huida Biotech Co., LTD  
Telephone: 0571-89903022 18679456698
Website: www.huidacollection.cn
Company Name: Lingyuan Bebiansen Biological Technology Co., Ltd  
Telephone: 18642120371
Website: https://www.bebiosion.com/
Company Name: TargetMol Chemicals Inc.  
Telephone: 4008200310 15002144251
Website: https://www.targetmol.cn/
Company Name: Shanghai YuZn Pharm. Technology Co.,Ltd.  
Telephone: 15921286451; 15921286451
Website: https://www.chemicalbook.com/ShowSupplierProductsList642122/0_EN.htm
Company Name: Meryer (Shanghai) Chemical Technology Co., Ltd.  
Telephone: 18621169109
Website: http://www.x-labseek.com/
Tags:184475-56-7 Related Product Information
104-47-2 150-76-5 90-05-1 104-94-9 100-66-3 456-55-3 123-11-5 184475-35-2 253-82-7 75-45-6